The decrease of PON-1 activities has been associated with serum ferritin and transferrin in several diseases, such as Parkinson disease [41], inflammatory bowel disease [42], iron deficiency anemia [43], hereditary hemochromatosis with iron overload [36], and in beta-thalassemia [44,45]. Here, PON1 is linked to Beta-thalassemia.